Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares? [Yahoo! Finance]
Adaptive Biotechnologies Corporation (ADPT)
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adhc.com
Company Research
Source: Yahoo! Finance
Stock in a series of open-market transactions between April 14 and April 16, 2026, with shares sold at a weighted average price of around $14.45 per share, according to the SEC Form 4 filing Transaction summary Metric Value Shares sold (direct) Transaction value ~$826,000 Post-transaction shares (direct) Post-transaction value (direct ownership) ~$5.75 million Transaction value based on SEC Form 4 weighted average purchase price ($14.45); post-transaction value based on April 16, 2026, market close ($14.08). Key questions What was the structure and purpose of this transaction, given the derivative context? This event involved the exercise of 44,166 options for Common Stock, with all resulting shares immediately sold—demonstrating a liquidity event rather than an open-market share disposition from long-term holdings. How did this sale impact Rubinstein's direct ownership and capacity for future transactions? Direct Common Stock holdings declined by 12.29%,
Show less
Read more
Impact Snapshot
Event Time:
ADPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADPT alerts
High impacting Adaptive Biotechnologies Corporation news events
Weekly update
A roundup of the hottest topics
ADPT
News
- Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026GlobeNewswire
- A Look At Adaptive Biotechnologies (ADPT) Valuation After Q4 2025 Beat And New Pfizer Agreements [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last? [Yahoo! Finance]Yahoo! Finance
ADPT
Earnings
- 2/5/26 - Beat
ADPT
Sec Filings
- 4/16/26 - Form 4
- 4/13/26 - Form 4
- 4/10/26 - Form 4
- ADPT's page on the SEC website